Itβs always a great start to the day to learn we have one more drug to offer patients with r/r leukemia! ποΈπ©Έπ https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-revumenib-relapsed-or-refractory-acute-leukemia-kmt2a-translocation
Comments